ALS drug Relyvrio withdrawn from market after failed clinical trial
By Mira Cheng, CNN (CNN) — Amylyx Pharmaceuticals announced Thursday that it has begun the process of voluntarily withdrawing its ALS drug, Relyvrio, from the market after it failed to prove efficacy in a large clinical trial. “Relyvrio will no longer be available for new patients as of today. Patients currently on therapy in the
Continue Reading